9-36199035-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001833.4(CLTA):āc.312G>Cā(p.Gln104His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000211 in 1,613,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001833.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152218Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000131 AC: 33AN: 251494Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135922
GnomAD4 exome AF: 0.000219 AC: 320AN: 1461756Hom.: 0 Cov.: 30 AF XY: 0.000201 AC XY: 146AN XY: 727170
GnomAD4 genome AF: 0.000138 AC: 21AN: 152218Hom.: 0 Cov.: 31 AF XY: 0.0000941 AC XY: 7AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.312G>C (p.Q104H) alteration is located in exon 3 (coding exon 3) of the CLTA gene. This alteration results from a G to C substitution at nucleotide position 312, causing the glutamine (Q) at amino acid position 104 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at